Healthcare -
Biotechnology - NASDAQ - US
$ 7.47
1.41 %
$ 160 M
Market Cap
-1.59
P/E
ENTA - OPERATING INCOME
Operating Income ENTA - Enanta Pharmaceuticals, Inc.
-122 M
LAST VALUE
0.87%
2 YEAR CAGR
-33.95%
5 YEAR CAGR
-22.17%
10 YEAR CAGR